Joshua Silverman Pharma Cyte Biotech, Inc. (PMCB) insider trading activity

Joshua Silverman is CEO and President of PharmaCyte Biotech, Inc.. Currently has a direct ownership of 416,250 shares of PMCB, which is worth approximately $328,837. The most recent transaction as insider was on Jan 07, 2026, when has been sold 40,000 shares (Common Stock) at a price of $0.83 per share, resulting in proceeds of $33,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 416K

n/a 3M change

n/a 12M change

Total Value Held $328,837

Joshua Silverman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 07 2026	BUY Open market or private purchase	$33,200 $0.83 p/Share	40,000 Added 8.77%	416,250 Common Stock
Jan 06 2026	BUY Open market or private purchase	$23,700 $0.79 p/Share	30,000 Added 7.38%	376,250 Common Stock
Jan 05 2026	BUY Open market or private purchase	$23,400 $0.78 p/Share	30,000 Added 7.97%	346,250 Common Stock
Dec 12 2025	SELL Payment of exercise price or tax liability	$263,925 $1.02 p/Share	258,750 Reduced 45.0%	316,250 Common Stock
Dec 12 2025	BUY Grant, award, or other acquisition	-	575,000 Added 50.0%	575,000 Common Stock

Also insider at

AYRO

AYRO, Inc. Consumer Cyclical

Chief Executive Officer

PTPI

Petros Pharmaceuticals, Inc. Healthcare

Director

MYMD

MyMD Pharmaceuticals, Inc. Healthcare

Executive Chairman

SNPX

Synaptogenix, Inc. Healthcare

Executive Chairman

FEMY

FEMASYS INC Healthcare